The Glassware Core Facility provides Cancer Center laboratory researchers with clean and sterile glassware for cell culture, molecular biology and biochemistry experiments. In addition to washing and sterilizing glassware for individual laboratories, this facility washes, sterilizes and delivers glass bottles to the Bioreagents and Cell Culture Core Facility for preparation of sterile culture media. The Core also prepares double-deionized and distilled water in large quantities for use in the preparation of reagents and sterilizes pipettes for molecular biology experiments. The Core Facility is located at three sites: the Norris building, the Cancer Research Laboratory (CRL), and the Smith Research Tower at Childrens Hospital Los Angeles (CHLA). The 1,300 sq. ft. Norris space contains two automatic dishwashers, two autoclaves, and a drying oven. The CRL houses a dishwasher and an autoclave in 1,000 sq. ft. The CHLA space has an autoclave and dishwashing facilities. The Glassware Core Facility serves 54 Cancer Center members and their research groups, approximately 350 scientists and technical staff in total. The CCSG supports 4.5 FTE glassware technicians and one is supported by chargebacks. The Glassware Core Facility is supervised by Joseph Landolph, Ph.D., Associated Professor of Molecular Microbiology and Immunology. Mr. Bill Taylor, Director of General Services, is the manager of the daily operations at Norris and CRL. The glassware services at CHLA are overseen by Dr. Ambrose Jong, Ph.D., Associate Professor of Pediatrics and Molecular Microbiology and Immunology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA014089-26S1
Application #
6504883
Study Section
Project Start
2001-04-06
Project End
2001-11-30
Budget Start
Budget End
Support Year
26
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90033
McSkane, Michelle; Stintzing, Sebastian; Heinemann, Volker et al. (2018) Association Between Height and Clinical Outcome in Metastatic Colorectal Cancer Patients Enrolled Onto a Randomized Phase 3 Clinical Trial: Data From the FIRE-3 Study. Clin Colorectal Cancer 17:215-222.e3
Khanova, Elena; Wu, Raymond; Wang, Wen et al. (2018) Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients. Hepatology 67:1737-1753
Brunette, Laurie L; Mhawech-Fauceglia, Paulette Y; Ji, Lingyun et al. (2018) Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study. BMC Cancer 18:970
Tokunaga, Ryuma; Cao, Shu; Naseem, Madiha et al. (2018) Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy. Clin Colorectal Cancer :
Lang, Julie E; Brownson, Kirstyn E (2018) ASO Author Reflections: The Whole Transcriptome Landscape of Circulating Tumor Cells in Nonmetastatic Breast Cancer. Ann Surg Oncol :
Poulard, Coralie; Baulu, Estelle; Lee, Brian H et al. (2018) Increasing G9a automethylation sensitizes B acute lymphoblastic leukemia cells to glucocorticoid-induced death. Cell Death Dis 9:1038
Guo, Yu; Perez, Andrew A; Hazelett, Dennis J et al. (2018) CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops. Genome Biol 19:160
Milam, Joel; Slaughter, Rhona; Tobin, Jessica L et al. (2018) Childhood Cancer Survivorship and Substance Use Behaviors: A Matched Case-Control Study Among Hispanic Adolescents and Young Adults. J Adolesc Health 63:115-117
Singh, Hardeep P; Wang, Sijia; Stachelek, Kevin et al. (2018) Developmental stage-specific proliferation and retinoblastoma genesis in RB-deficient human but not mouse cone precursors. Proc Natl Acad Sci U S A 115:E9391-E9400
Suenaga, Mitsukuni; Schirripa, Marta; Cao, Shu et al. (2018) Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer. Pharmacogenomics J 18:623-632

Showing the most recent 10 out of 842 publications